Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0012 | 0.0008 | 0.011 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0019 | 1 |
Echinococcus multilocularis | bloom syndrome protein | 0.0029 | 0.0033 | 0.0198 |
Entamoeba histolytica | recQ family helicase, putative | 0.0015 | 0.0014 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.0286 | 1 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0012 | 0.0008 | 0.011 |
Schistosoma mansoni | Smad4 | 0.001 | 0.0005 | 0.0188 |
Loa Loa (eye worm) | hypothetical protein | 0.6946 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.0201 | 0.0201 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.002 | 0.0019 | 0.5 |
Trypanosoma brucei | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.2729 | 0.3924 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0286 | 1 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0012 | 0.0008 | 0.0008 |
Loa Loa (eye worm) | RecQ helicase | 0.0029 | 0.0033 | 0.0033 |
Leishmania major | malonyl-coa decarboxylase-like protein | 0.2729 | 0.3924 | 1 |
Loa Loa (eye worm) | Smad1 | 0.001 | 0.0005 | 0.0005 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0012 | 0.0008 | 0.0022 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0286 | 0.201 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0199 | 0.0199 |
Treponema pallidum | ATP-dependent DNA helicase | 0.0006 | 0.0000000000071097 | 0.5 |
Schistosoma mansoni | DNA helicase recq5 | 0.0012 | 0.0008 | 0.0296 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0029 | 0.0033 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0008 | 0.4422 |
Schistosoma mansoni | DNA helicase recq1 | 0.0012 | 0.0008 | 0.0296 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.001 | 0.0005 | 0.0005 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.1402 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0005 | 0.0188 |
Schistosoma mansoni | smad | 0.001 | 0.0005 | 0.0188 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0029 | 0.0033 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0008 | 0.0008 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0012 | 0.0008 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0005 | 0.0188 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.001 | 0.0005 | 0.0188 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.001 | 0.0005 | 0.0005 |
Wolbachia endosymbiont of Brugia malayi | malonyl-CoA decarboxylase | 0.6946 | 1 | 0.5 |
Echinococcus granulosus | bloom syndrome protein | 0.0029 | 0.0033 | 0.0984 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0008 | 0.0003 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0199 | 0.0199 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0023 | 0.0024 | 0.0846 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0025 | 0.0028 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0286 | 1 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0008 | 0.0003 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0015 | 0.0014 | 0.0034 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.2729 | 0.3924 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0199 | 0.0194 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0029 | 0.0033 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0008 | 0.4422 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0005 | 0.0188 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.2729 | 0.3924 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0012 | 0.0008 | 0.0022 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.